SWK Holdings Corporation (SWKH)
Market Cap | 216.95M |
Revenue (ttm) | 37.76M |
Net Income (ttm) | 15.89M |
Shares Out | 12.50M |
EPS (ttm) | 1.25 |
PE Ratio | 13.87 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 478 |
Open | 17.36 |
Previous Close | 17.34 |
Day's Range | 17.36 - 17.36 |
52-Week Range | 15.26 - 18.75 |
Beta | 0.33 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | May 9, 2024 |
About SWKH
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to... [Read more]
Financial Performance
In 2023, SWK Holdings's revenue was $37.76 million, a decrease of -8.98% compared to the previous year's $41.48 million. Earnings were $15.89 million, an increase of 17.76%.
Financial StatementsNews
SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023
Conference Call and Live Audio Webcast Scheduled for Thursday, March 21, 2024, at 10:00 a.m. ET Corporate Highlights Fourth quarter 2023 and 2022 net income was $2.8 million Full year 2023 net income ...
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
DALLAS, TX / ACCESSWIRE / January 23, 2024 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercia...
SWK Holdings Corporation Announces Financial Results for Third Quarter 2023
Conference Call and Live Audio Webcast Scheduled for Thursday, November 9, 2023, at 10:00 a.m. ET Corporate Highlights Third quarter of 2023 GAAP net income was $4.5 million or $0.36 per diluted share...
SWK Holdings Corporation to Report Third Quarter 2023 Financial Results
Conference Call and Live Audio Webcast Scheduled for Thursday, November 9, 2023, at 10:00 a.m. ET DALLAS , Nov. 6, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"...
SWK Holdings Corporation Announces B. Riley Securities Exercises Option to Purchase Approximately $3 Million in Additional Unsecured Senior Notes
DALLAS , Oct. 30, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that B. Riley Securities has exercised its option to purchase $2,968,750 in addi...
SWK Holdings Corporation Increases Revolving Credit Facility to $60 Million
DALLAS , Oct. 11, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life-science-focused, specialty finance company catering to small- and mid-sized commercial-s...
SWK Holdings Corporation Announces Closing of Public Offering of Senior Unsecured Notes Due 2027
DALLAS , Oct. 3, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it has completed its previously announced registered underwritten public off...
SWK Holdings Corporation Announces Pricing of Public Offering of Senior Unsecured Notes Due 2027
DALLAS , Sept. 28, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it has priced its previously announced registered underwritten public offe...
SWK Holdings Corporation Announces Public Offering of Senior Unsecured Notes Due 2028
DALLAS , Sept. 26, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it plans to offer $30 million in aggregate principal amount of senior unse...
SWK Holdings Corporation Announces Financial Results for Second Quarter 2023
Conference Call and Live Audio Webcast Scheduled for Wednesday, August 9, 2023, at 5:00 p.m. ET Corporate Highlights Second quarter 2023 GAAP net income was $3.9 million or $0.31 per diluted share, co...
SWK Holdings Corporation to Report Second Quarter 2023 Financial Results
Conference Call and Live Audio Webcast Scheduled for Wednesday, August 9, 2023, at 5:00 p.m. ET DALLAS , Aug. 8, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), ...
SWK Holdings Corporation Announces New Credit Facility with $45 Million Committed at Close
DALLAS , June 28, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-st...
SWK Holdings Corporation Announces Financial Results for First Quarter 2023
Conference Call and Live Audio Webcast Scheduled for Thursday, May 11, 2023, at 10:00 a.m. ET Corporate Highlights First quarter 2023 GAAP net income was $4.6 million or $0.36 per diluted share, compa...
SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full Year 2022
Conference Call and Live Audio Webcast Scheduled for Today, April 3, 2023, at 10:00 a.m. ET Corporate Highlights Jody Staggs named President and Chief Executive Officer Appointed Laurie Dotter as Chai...
SWK Holdings Corporation to Report Fourth Quarter and Full-Year 2022 Financial Results
Conference Call and Live Audio Webcast Scheduled for Monday, April 3, 2023, at 10:00 a.m. ET DALLAS , March 31, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a...
SWK Holdings Appoints Jerry Albright to Board of Directors
DALLAS , March 15, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-s...
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Fourth Quarter and Full Year 2022 Financial Results to be Announced in March DALLAS , Jan. 31, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-foc...
SWK Holdings Names Jody Staggs Chief Executive Officer and Appoints Laurie Dotter as Chair of the Board
Mr. Staggs elevated from "interim" to "permanent" CEO as SWK advances multiple initiatives in 2023 Ms. Dotter joined SWK's Board of Directors in February 2022 DALLAS , Jan. 3, 2023 /PRNewswire/ -- SWK...
SWK Holdings Corporation Announces Upsizing of Credit Facility up to $50 Million
DALLAS , Nov. 16, 2022 /PRNewswire/ -- SW K Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-s...
SWK Holdings Corporation Announces Financial Results for Third Quarter 2022
Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET Corporate Highlights Successful leadership transition with Jody Staggs named President and Interim Ch...
SWK Holdings Corporation to Report Third Quarter 2022 Financial Results
Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET DALLAS , Nov. 8, 2022 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company"...
Enteris BioPharma Presents Study of Ovarest® Demonstrating Oral Delivery Comparable to or Exceeding Injectable Leuprolide
Oral Presentation Delivered at the American Society for Reproductive Medicine Scientific (ASRM) 2022 Congress & Expo BOONTON, N.J. , Oct. 26, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnol...
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics
Milestone payment highlights ongoing clinical progress of Oral KORSUVA™ DALLAS , Oct. 10 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance compan...
SWK Holdings Enhances Executive Management Team and Expands Underwriting Team
Yvette Heinrichson promoted to Chief Financial Officer John David Tamas promoted to Director of Underwriting DALLAS , Oct. 3, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the...
Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides
Physicochemical properties of peptides can provide key insights to potential success of oral delivery BOONTON, N.J. , Sept. 12, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company de...